Literature DB >> 11482335

Retinal pigment epithelial tear with vitreomacular attachment: a novel pathogenic feature.

C H Meyer1, C A Toth.   

Abstract

BACKGROUND: The development of tears of the retinal pigment epithelium (RPE) has classically been described with or without choroidal neovascularization (CNV) or after laser treatment. Tangential shear forces within the RPE or CNV are usually considered to cause the dehiscence.
METHODS: Three patients with CNV and spontaneous RPE tear and additional vitreomacular traction were examined by fluorescein angiography (FA), optical coherence tomography (OCT) and kinetic ultrasound.
RESULTS: From the pre-tear to the tear stage a sudden decrease in vision was observed. Fluorescein angiographic images demonstrated RPE-tear formation with blocked filling in the area of the contracted RPE and a well-demarcated hyperfluorescence in the bed of the torn RPE. OCT-scans demonstrated vitreomacular traction at the foveal area in all three cases. Kinetic ultrasound revealed vitreous attachments at the optic disc and fovea.
CONCLUSION: Magnitude, variation of mechanical forces, and the continuous shear stress of the aged vitreous gel transmitted across vitreoretinal attachments may cause a chronic stimulus to retina and RPE. Vitreomacular traction may contribute to the subsequent formation of RPE tears via mechanical or cell mediator pathways.

Entities:  

Mesh:

Year:  2001        PMID: 11482335     DOI: 10.1007/s004170100259

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  18 in total

1.  High incidence of vitreomacular traction in recurrent choroidal neovascularisation after repeated photodynamic therapy.

Authors:  J C Schmidt; S Mennel; S Hörle; C H Meyer
Journal:  Br J Ophthalmol       Date:  2006-07-19       Impact factor: 4.638

2.  Retinal pigment epithelium detachment associated with vitreomacular traction syndrome-case report.

Authors:  Ilias Georgalas; Catherin Heatley; Eric Ezra
Journal:  Int Ophthalmol       Date:  2008-07-15       Impact factor: 2.031

3.  Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis).

Authors:  David Sarraf; Anthony Joseph; Ehsan Rahimy
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

4.  Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.

Authors:  Joo Youn Shin; Moonjung Choi; Byunghoon Chung; Suk Ho Byeon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-07       Impact factor: 3.117

5.  [Bilateral serous detachment of the neurosensory retina and retinal pigment epithelium with rip of the peripheral pigment epithelium].

Authors:  A Hager; W Wiegand
Journal:  Ophthalmologe       Date:  2006-11       Impact factor: 1.059

6.  Change in vision after retinal pigment epithelium tear following the use of anti-VEGF therapy for age-related macular degeneration.

Authors:  Shane R Durkin; Lachlan D M Farmer; Susith Kulasekara; Jagjit Gilhotra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-08       Impact factor: 3.117

7.  Macular translocation with 360 degrees retinotomy for retinal pigment epithelial tear.

Authors:  Faik Gelisken; Khakima Karim-Zoda; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-01-14       Impact factor: 3.117

8.  Retinal Pigment Epithelium Tear.

Authors:  Aleksandra V Rachitskaya; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2014-12-06

9.  [Intravitreal administration of triamcinolone and bevacizumab for pigment epithelial detachment in conjunction with AMD].

Authors:  A Frimpong-Boateng; M A Varde; F Rüfer; A Bunse; J Roider
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

Review 10.  Physiology of vitreous surgery.

Authors:  Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.